Suncoast Research Associates, LLC | Miami, FL

Research site
9260 Sunset Drive building 6 Suite 107, Miami, Florida, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


7 of 14
Status: Active
Trial type: Interventional
Funder type: Industry

A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older (Engage)

The purpose of this study is to show that high-dose quadrivalent seasonal influenza vaccine (HD QIV) given together with 9-valent extraintestinal pat...

Active, not recruiting
Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
Biological: ExPEC9V
Biological: Placebo

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Atrial Fibrillation
Drug: Placebo
Drug: Apixaban Placebo

The purpose of this study is to generate safety and immunogenicity data and establish a proof-of-concept of clinical benefit of the mRNA-1608 vaccine...

Active, not recruiting
Genital Herpes
Biological: mRNA-1608
Biological: BEXSERO

The main purpose of this study is to evaluate the safety and immunogenicity of mRNA-1345 RSV vaccine when coadministered with a high dose (HD) quadri...

Active, not recruiting
Respiratory Syncytial Virus
Biological: Fluzone HD
Biological: Placebo

The purpose of this phase 3 multicenter, randomized, double-blind, placebo-controlled rollover study is to evaluate the safety and long-term immunoge...

Chikungunya Virus Infection
Biological: PXVX0317 vaccine booster
Biological: Placebo booster

This is a Phase 2/3, randomized, double-blind study to evaluate the safety and immunogenicity of different booster dose levels of the monovalent seve...

Active, not recruiting
Biological: NVX-CoV2601 (5μg)
Biological: NVX-CoV2601 (35μg)
Recently updated

Brief Summary of Stage 1:The purpose Stage 1 (Phase I/IIa) is to assess the safety and immunogenicity of a single intramuscular (IM) injection of 3 d...

Respiratory Syncytial Virus Immunization
Biological: RSV vaccine candidate formulation 2
Biological: RSV vaccine candiate formulation 1

Trial conditions

Chikungunya Fever (3 trials)
Human Influenza (2 trials)
Atrial Fibrillation (1 trial)
COVID-19 (1 trial)
Escherichia coli Infecti... (1 trial)
Herpes Genitalis (1 trial)
Herpes Simplex (1 trial)
Pneumococcal Infections (1 trial)
Respiratory Syncytial Vi... (1 trial)
Respiratory Tract Diseas... (1 trial)

And 1 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems